I wondered if Leron/Vyro could be competitive on a

I wondered if Leron/Vyro could be competitive on a financial basis with Keytruda and Opdivo.

Answer is yes. This from the Keytruda.com website:

Quote:

---

The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $9,869.94. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $19,739.88. * The total cost of KEYTRUDA over the course of treatment is the same, whether given every 3 weeks or every 6 weeks.

---

And this is from BMS pricing dot com:

"The list price for an OPDIVO 360 mg and YERVOY 1 mg/kg infusion is $25,247 and the list price for an OPDIVO 360 mg alone infusion is $10,019. * However, most patients will pay less than the list price."

So that's another benefit via Leron. Costs a lot less.